|
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other similar complaints from this lot.Based on the information provided, a definitive cause for the reported complaints could not be determined.It was reported by the account that the armada 35 balloon was successfully used for post dilatation per standard procedure.But during advancement, the balloon touched the edge of the implanted stent and pushed the implanted stent shortening/crushing the absolute pro vascular stent.In this case, it is possible that the absolute pro was stent was not full apposed such that the armada interacted with the edge of the stent resulting in the reported difficulty advancing the device and subsequently resulted in damage to the absolute pro; however, a conclusive cause cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.The additional device referenced in b5 and d10 is filed under separate medwatch report number.
|